Close



Apr 10, 2024 08:02AM
Apr 10, 2024 08:00AM
Apr 5, 2024 04:00PM
Apr 1, 2024 07:03AM
Apr 1, 2024 07:00AM
Mar 28, 2024 08:00AM
Mar 11, 2024 08:00AM Arcutis Promotes Todd Tucker to Chief Human Resources Officer
Mar 10, 2024 04:00PM
Mar 9, 2024 04:00PM
Mar 5, 2024 04:00PM
Mar 4, 2024 04:00PM
Mar 4, 2024 08:00AM
Feb 29, 2024 05:00PM
Feb 28, 2024 11:32PM Arcutis Biotherapeutics (ARQT) Announces Pricing of $150 Mln Public Offering
Feb 28, 2024 11:30PM
Feb 28, 2024 04:10PM
Feb 28, 2024 04:10PM
Feb 28, 2024 04:00PM
Feb 28, 2024 04:00PM
Feb 27, 2024 05:50AM
Feb 16, 2024 08:00AM Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
Feb 6, 2024 04:00PM
Jan 31, 2024 08:00AM
Jan 29, 2024 08:00AM
Jan 22, 2024 08:02AM
Jan 22, 2024 08:00AM
Jan 16, 2024 05:19AM
Jan 14, 2024 04:00AM ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids
Jan 14, 2024 04:00AM
Dec 15, 2023 05:12PM
Dec 15, 2023 05:11PM
Nov 29, 2023 08:02AM
Nov 29, 2023 08:00AM
Nov 3, 2023 07:30AM
Oct 13, 2023 08:02AM Arcutis Biotherapeutics (ARQT) Presents Positive Patient-Reported Outcome Data from the Pivotal ARRECTOR Phase 3 Trial
Oct 13, 2023 08:00AM
Oct 6, 2023 08:00AM
Oct 6, 2023 08:00AM
Sep 27, 2023 08:01AM
Sep 27, 2023 08:00AM
Sep 19, 2023 07:30AM
Sep 19, 2023 07:30AM Arcutis Announces Positive Results from INTEGUMENT-PED Pivotal Phase 3 Trial of Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
Sep 12, 2023 07:30AM
Sep 7, 2023 08:16AM
Sep 7, 2023 08:15AM
Aug 10, 2023 08:17AM
Aug 10, 2023 08:16AM
Aug 8, 2023 04:02PM
May 24, 2023 05:00PM Arcutis Biotherapeutics (ARQT) Announces Leadership Transition
May 24, 2023 05:00PM

251,395 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All